Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BRL-15572 dihydrochloride (BRL 15573 dihydrochloride) 是一种 5-HT1D 受体拮抗剂,pKi 为 7.9,对 5-HT1A 和 5-HT2B 受体也显示出相当大的亲和力,其选择性是 5-HT1B 受体的 60 倍。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 193 | 现货 | ||
5 mg | ¥ 417 | 现货 | ||
10 mg | ¥ 587 | 现货 | ||
25 mg | ¥ 984 | 现货 | ||
50 mg | ¥ 1,770 | 现货 | ||
100 mg | ¥ 2,496 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 441 | 现货 |
产品描述 | BRL-15572 dihydrochloride (BRL 15573 dihydrochloride) is a 5-HT1D receptor antagonist with pKi of 7.9, also shows a considerable affinity at 5-HT1A and 5-HT2B receptors, exhibiting 60-fold selectivity over 5-HT1B receptor. |
靶点活性 | 5-HT1A:7.7(pKi), 5-HT2B:7.4(pKi), 5-HT2A:6.6(pKi), 5-HT1D:7.9(pKi), 5-HT7:6.3(pKi) |
体外活性 | BRL-15572 displays high affinity and selectivity for h5-HT1D receptors. BRL-15572 has 60-fold higher affinity for h5-HT1D than 5-HT1B receptors. BRL-15572 binds to h5-HT1B and h5-HT1D receptors with pKB of less than 6 and 7.1, respectively. BRL-15572 stimulates [35S]GTP γ S binding in both cell lines, with potencies that correlated with their receptor binding affinities in both h5-HT1B and h5-HT1D receptor expressing cell lines. BRL-15572 reveals receptor binding affinities for 5-HT1A, 5-HT1B, 5-HT1E, 5-HT1F, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT6 and 5-HT7 with pKi of 7.7, 6.1, 5.2, 6.0, 6.6, 7.4, 6.2, 5.9 and 6.3, respectively. In the h5-HT1D cell line, both BRL-15572 (1 μM) shifts the 5-HT concentration response curve with pKB of 7.1, respectively. BRL-15572 does have moderately high affinity at human 5-HT1A and 5-HT2B receptors. [1] In human atrial appendages, the electrically evoked tritium overflow is inhibited by 5-HT in a manner susceptible to antagonism by BRL-15572 (300 nM; 23 times Ki at h5-HT1D receptors). [2] The inhibitory effect of 5-HT on the K+-evoked overflow of glutamate is antagonized by the h5-HT1D receptor ligand BRL-15572. BRL-15572 (1 μM) is unable to modify the effect of 5-HT at the autoreceptor regulating [3H]5-HT release. [3] The selective 5-HT1D/1B receptor antagonist BRL 15572 inhibits the effect of the agonist L-694 247. [4] |
体内活性 | In diabetic pithed rats, administration of the selective 5-HT1D receptor antagonist BRL-15572 (2 mg/kg) does not modify the decreased HR induced by vagal electrical stimulation. The effects of L-694,247 (50 μg/kg), a selective agonist for non-rodent 5-HT1B and 5-HT1D receptors, on the vagally induced bradycardia are not apparent after pretreatment with BRL-15572. [5] |
细胞实验 | [35S]GTPγS binding studies. [35S]GTPγS binding studies in CHO cells expressing the h5-HT1B or h5-HT1D receptors are performed. In brief, membranes from 1 × 106 cells are preincubated at 30°C for 30 minutes, in HEPES buffer (HEPES [20 mM], MgCl2 [3 mM], NaCl [100 mM], ascorbate [0.2 mM]), containing GDP (10 μ M), with or without BRL-15572. The reaction is started by the addition of 10 μL of [35S]GTPγS (100 pM, assay concentration) followed by a further 30 minutes incubation at 30°C. Non-specific binding is determined by addition of unlabelled GTPγS (10 μM), prior to the addition of cells. The reaction is stopped by rapid filtration using Whatman GF/B grade filters followed by five washes with ice-cold HEPES buffer. Radioactivity is determined by liquid scintillation spectrometry.(Only for Reference) |
别名 | 四氢罂粟碱盐酸盐, BRL 15573 dihydrochloride |
分子量 | 479.87 |
分子式 | C25H27ClN2O·2HCl |
CAS No. | 193611-72-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 89 mg/mL (185.5 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: 38 mg/mL (79.2 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / Ethanol | 1 mM | 2.0839 mL | 10.4195 mL | 20.839 mL | 52.0974 mL |
5 mM | 0.4168 mL | 2.0839 mL | 4.1678 mL | 10.4195 mL | |
10 mM | 0.2084 mL | 1.0419 mL | 2.0839 mL | 5.2097 mL | |
20 mM | 0.1042 mL | 0.521 mL | 1.0419 mL | 2.6049 mL | |
50 mM | 0.0417 mL | 0.2084 mL | 0.4168 mL | 1.0419 mL | |
DMSO | 100 mM | 0.0208 mL | 0.1042 mL | 0.2084 mL | 0.521 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
BRL-15572 dihydrochloride 193611-72-2 GPCR/G Protein Neuroscience 5-HT Receptor h5-HT1D BRL 15572 dihydrochloride BRL-15573 BRL15573 Dihydrochloride BRL-15572 四氢罂粟碱盐酸盐 BRL 15572 Dihydrochloride BRL 15573 BRL 15572 BRL15572 BRL 15573 dihydrochloride BRL-15573 Dihydrochloride BRL15573 Inhibitor Serotonin Receptor BRL15572 dihydrochloride 5-hydroxytryptamine Receptor inhibit BRL 15573 Dihydrochloride BRL15572 Dihydrochloride BRL-15572 Dihydrochloride inhibitor